0001677995-16-000001.txt : 20160627 0001677995-16-000001.hdr.sgml : 20160627 20160627144508 ACCESSION NUMBER: 0001677995-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20160627 DATE AS OF CHANGE: 20160627 EFFECTIVENESS DATE: 20160627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001677995 IRS NUMBER: 454872095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-265826 FILM NUMBER: 161733111 BUSINESS ADDRESS: STREET 1: 846 STILL CREEK LANE CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3019632400 MAIL ADDRESS: STREET 1: 846 STILL CREEK LANE CITY: GAITHERSBURG STATE: MD ZIP: 20878 D 1 primary_doc.xml X0707 D LIVE 0001677995 Cerium Pharmaceuticals, Inc. 846 STILL CREEK LANE GAITHERSBURG MD MARYLAND 20878 3019632400 DELAWARE None None Corporation true 2012 Gregg Lapointe 846 Still Creek Lane Gaithersburg MD MARYLAND 20878 Executive Officer Director Biotechnology Decline to Disclose 06c false 2016-06-13 false true true false 0 7273674 2273681 4999993 Offering includes warrants, the monetary consideration for which may not be paid until the exercise of said warrants. false 9 0 0 0 false Cerium Pharmaceuticals, Inc. /s/ Gregg Lapointe Gregg Lapointe Chief Executive Officer 2016-06-27